Literature DB >> 16681989

Can we screen for pelvic organ prolapse without a physical examination in epidemiologic studies?

Matthew D Barber1, Nikki L Neubauer, Victoria Klein-Olarte.   

Abstract

OBJECTIVE: Large population-based epidemiologic studies of pelvic organ prolapse are rare. One barrier is the need for physical examination in order to confirm disease status. The objectives of this study were to develop a simple screening question for pelvic organ prolapse (POP) and to evaluate its test characteristics in high and low prevalence populations. STUDY
DESIGN: Data from 100 women enrolled in the validation study of the Pelvic Floor Distress Inventory (PFDI) were used to identify the question or questions that most accurately identified women with advanced pelvic organ prolapse. After identifying an accurate and reliable screening question from this original group, its test characteristics were evaluated prospectively in 2 additional distinct populations: a group of 120 women presenting to a tertiary care urogynecology clinic (High prior probability of POP) and 448 women presenting to a nurse practitioner for annual gynecologic examination (Low prior probability of POP). Subjects in these 2 groups each completed the screening question and underwent a POPQ examination by a blinded examiner.
RESULTS: A single question was identified from the original study population that most accurately and reliably identified those women with POP "Do you usually have a bulge or something falling out that you can see or feel in your vaginal area?" An affirmative answer to this question was 96% sensitive (95%CI 92-100) and 79% specific (95%CI 77-92) for prolapse beyond the hymen. The 1-week test-retest reliability was good (kappa .84). The prevalence of POP in this group was 29%. No other single question or group of questions had better test characteristics. When prospectively evaluated in the second High probability population (prevalence 39%), similar test characteristics were noted: sensitivity 85% (95%CI 71-93), specificity 86% (95%CI 75-92). However, when evaluated in the Low prior probability group (POP prevalence 3.8%) the specificity improved to 99% (95%CI 98-99), while the sensitivity decreased dramatically to 35% (95%CI 15-61).
CONCLUSION: Screening for POP without a physical examination is subject to spectrum bias. Spectrum bias occurs when a diagnostic test performs differently in different groups of patients. In groups with a high prior probability of POP, a simple screening question can accurately screen for advanced POP without a physical exam. However, in groups with a low prior probability of POP such as might be seen in a population-based epidemiologic study, this question has poor sensitivity.

Entities:  

Mesh:

Year:  2006        PMID: 16681989     DOI: 10.1016/j.ajog.2006.02.050

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  41 in total

Review 1.  A systematic review of clinical studies on dynamic magnetic resonance imaging of pelvic organ prolapse: the use of reference lines and anatomical landmarks.

Authors:  Suzan R Broekhuis; Jurgen J Fütterer; Jelle O Barentsz; Mark E Vierhout; Kirsten B Kluivers
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-03-07

2.  Symptomatic pelvic organ prolapse at midlife, quality of life, and risk factors.

Authors:  Xavier Fritel; Noëlle Varnoux; Marie Zins; Gérard Breart; Virginie Ringa
Journal:  Obstet Gynecol       Date:  2009-03       Impact factor: 7.661

3.  Pelvic Floor Symptoms and Spinal Curvature in Women.

Authors:  Isuzu Meyer; Tatum A McArthur; Ying Tang; Jessica L McKinney; Sarah L Morgan; Holly E Richter
Journal:  Female Pelvic Med Reconstr Surg       Date:  2016 Jul-Aug       Impact factor: 2.091

4.  The Design of a Randomized Trial of Vaginal Surgery for Uterovaginal Prolapse: Vaginal Hysterectomy With Native Tissue Vault Suspension Versus Mesh Hysteropexy Suspension (The Study of Uterine Prolapse Procedures Randomized Trial).

Authors:  Charles W Nager; Halina Zyczynski; Rebecca G Rogers; Matthew D Barber; Holly E Richter; Anthony G Visco; Charles R Rardin; Heidi Harvie; Dennis Wallace; Susan F Meikle
Journal:  Female Pelvic Med Reconstr Surg       Date:  2016 Jul-Aug       Impact factor: 2.091

5.  Prevalence of genital prolapse symptoms in primary care: a cross-sectional survey.

Authors:  Jason Cooper; Manjula Annappa; Davina Dracocardos; Wendy Cooper; Sara Muller; Christian Mallen
Journal:  Int Urogynecol J       Date:  2014-11-08       Impact factor: 2.894

6.  Association between vaginal bulge and anatomical pelvic organ prolapse during pregnancy and postpartum: an observational study.

Authors:  Cathrine Reimers; Jette E Stær-Jensen; Franziska Siafarikas; Kari Bø; Marie Ellström Engh
Journal:  Int Urogynecol J       Date:  2017-07-11       Impact factor: 2.894

7.  Relationship between the Pelvic Organ Prolapse Quantification system (POP-Q), the Pelvic Floor Impact Questionnaire (PFIQ-7), and the Pelvic Floor Distress Inventory (PFDI-20) before and after anterior vaginal wall prolapse surgery.

Authors:  P Teleman; E Laurikainen; I Kinne; R Pogosean; U Jakobsson; M Rudnicki
Journal:  Int Urogynecol J       Date:  2014-05-28       Impact factor: 2.894

8.  Pelvic floor symptoms and bone mineral density in women undergoing osteoporosis evaluation.

Authors:  Holly E Richter; Sarah L Morgan; Jonathan L Gleason; Jeff M Szychowski; Patricia S Goode; Kathryn L Burgio
Journal:  Int Urogynecol J       Date:  2013-02-07       Impact factor: 2.894

9.  Symptoms of pelvic floor dysfunction are poorly correlated with findings on clinical examination and dynamic MR imaging of the pelvic floor.

Authors:  Suzan R Broekhuis; Jurgen J Fütterer; Jan C M Hendriks; Jelle O Barentsz; Mark E Vierhout; Kirsten B Kluivers
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-07-14

10.  Prediction model and prognostic index to estimate clinically relevant pelvic organ prolapse in a general female population.

Authors:  Marijke C Ph Slieker-ten Hove; Annelies L Pool-Goudzwaard; Marinus J C Eijkemans; Regine P M Steegers-Theunissen; Curt W Burger; Mark E Vierhout
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.